Isolated neurosarcoidosis mimicking multiple sclerosis

References

1. ↵
   1. Ungprasert P,
   2. Crowson CS,
   3. Matteson EL

   (2017) Characteristics and long-term outcome of neurosarcoidosis: A opulation-based study from 1976-2013. Neuroepidemiology 48, 87–94.
2. ↵
   1. Ibitoye RT,
   2. Wilkins A,
   3. Scolding NJ

   (2017) Neurosarcoidosis: a clinical approach to diagnosis and management. J Neurol 264, 1023–1028.
3. ↵
   1. Tana C,
   2. Wegener S,
   3. Borys E,
   4. Pambuccian S,
   5. Tchernev G,
   6. Tana M,
   7. et al.

   (2015) Challenges in the diagnosis and treatment of neurosarcoidosis. Ann Med 47, 576–591.
4. ↵
   1. Wildner P,
   2. Stasiołek M,
   3. Matysiak M

   (2020) Differential diagnosis of multiple sclerosis and other inflammatory CNS diseases. Mult Scler Relat Dis 37, 101452.
5. ↵
   1. Arun T,
   2. Pattison L,
   3. Palace J

   (2020) Distinguishing neurosarcoidosis from multiple sclerosis based on CSF analysis: A retrospective cohort study. Neurology 94, e2545–e2554.
6. ↵
   1. Katdare A,
   2. Ursekar M

   (2015) Systematic imaging review: Multiple Sclerosis. Ann Indian Acad Neurol 18, 24–29.
7. ↵
   1. Voelkel JE,
   2. Loeb J,
   3. Rios S,
   4. Masoud A

   (2017) Longitudinally extensive spinal neurosarcoid from the brainstem to T3 - T4. Kans J Med 10, 17–19.
8. ↵
   1. Kingah P,
   2. Alam M,
   3. Chugh K,
   4. Kamholz J,
   5. Samavati L

   (2016) Role of pulmonary evaluation in diagnosis of neurosarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 33, 209–215.
9. ↵
   1. Picón Serrano C,
   2. Escoda Menéndez S,
   3. Gorospe Sarasúa L

   (2015) Sarcoidosis with neurological involvement imitating multiple sclerosis: the importance of thoracic imaging. Arch Bronconeumol 51, 307–308.
10. ↵
    1. Kemanetzoglou E,
    2. Andreadou E

    (2017) CNS demyelination with TNF-α Blockers. Curr Neurol Neurosci Rep 17, 36.